No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus

Human Immunology

Volumn 72, Issue 11, 2011, Pages 1091-1094

  Eisen, Damon P ^a   Marshall, Caroline ^a,b   Dean, Melinda M ^c   Sasadeusz, Joe ^a   Richards, Michael ^a   Buising, Kirsty ^d   Cheng, Allen ^e   Johnson, Paul D R ^f   Barr, Ian G ^g   McBryde, Emma S ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e ALFRED HOSPITAL   (Australia)

^f AUSTIN HEALTH   (Australia)

^g WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Deficiency; Influenza; Innate immunity; Mannose binding lectin; Pandemic

Indexed keywords

MANNOSE BINDING LECTIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE PERSONNEL; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INFLUENZA A (H1N1); INNATE IMMUNITY; MAJOR CLINICAL STUDY; MANNOSE BINDING LECTIN DEFICIENCY; METABOLIC DISORDER; PANDEMIC; PRIORITY JOURNAL;

ANTIBODIES, VIRAL; AUSTRALIA; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MANNOSE-BINDING LECTIN; PANDEMICS; PERSONNEL, HOSPITAL; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 80054116412     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.08.014     Document Type: Article

References (25)

1. Webb S.A., Pettila V., Seppelt I., Bellomo R., Bailey M., Cooper D.J., et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934.
2. Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W., et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991, 337:1569-1570.
3. Reading P.C., Morey L.S., Crouch E.C., Anders E.M. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 1997, 71:8204-8212.
4. Chang W.C., White M.R., Moyo P., McClear S., Thiel S., Hartshorn K.L., et al. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol 2010, 11:64.
5. Tokunaga H., Ushirogawa H., Ohuchi M. The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin. Virol J 2011, 8:50.
6. Eisen D.P., Dean M.M., Boermeester M.A., Fidler K.J., Gordon A.C., Kronborg G., et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008, 47:510-516.
7. Eisen D.P. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun 2010, 2:114-122.
8. Fidler K.J., Hilliard T.N., Bush A., Johnson M., Geddes D.M., Turner M.W., et al. Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax 2009, 64:150-155.
9. Marshall C., Kelso A., McBryde E.S., Barr I.G., Eisen D.P., Sasadeusz J., et al. Do frontline healthcare workers have increased risk of contracting pandemic (H1N1) 2009 influenza?. A prevalence and risk factor study. Emerging Infect Dis 2011, 17:1000-1006.
10. Minchinton R.M., Dean M.M., Clark T.R., Heatley S., Mullighan C.G. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002, 56:630-641.
11. Peterslund N.A., Koch C., Jensenius J.C., Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001, 358:637-638.
12. Eisen D.P., Stubbs J., Spilsbury D., Carnie J., Leydon J., Howden B.P. Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease. Clin Exp Immunol 2007, 149:97-102.
13. Brouwer M.C., de Gans J., Heckenberg S.G., Zwinderman A.H., van der Poll T., van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9:31-44.
14. Rantala A., Lajunen T., Juvonen R., Bloigu A., Silvennoinen-Kassinen S., Peitso A., et al. Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J Infect Dis 2008, 198:1247-1253.
15. Ytting H., Christensen I.J., Thiel S., Jensenius J.C., Svendsen M.N., Nielsen L., et al. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol 2007, 66:458-464.
16. Denholm J.T., Gordon C.L., Johnson P.D., Hewagama S.S., Stuart R.L., Aboltins C., et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010, 192:84-86.
17. Gordon C.L., Johnson P.D., Permezel M., Holmes N.E., Gutteridge G., McDonald C.F., et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 2010, 50:672-678.
18. Chang W.C., Hartshorn K.L., White M.R., Moyo P., Michelow I.C., Koziel H., et al. Recombinant chimeric lectins consisting of mannose-binding lectin and l-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol 2010, 81:388-395.
19. Gonzalez S.F., Lukacs-Kornek V., Kuligowski M.P., Pitcher L.A., Degn S.E., Kim Y.A., et al. Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes. Nat Immunol 2010, 11:427-434.
20. Schoepfer A.M., Flogerzi B., Seibold-Schmid B., Schaffer T., Kun J.F., Pittet V., et al. Low mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA). Am J Gastroenterol 2009, 104:2508-2516.
21. Lambourne J., Agranoff D., Herbrecht R., Troke P.F., Buchbinder A., Willis F., et al. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2009, 49:1486-1491.
22. Ytting H., Christensen I.J., Basse L., Lykke J., Thiel S., Jensenius J.C., et al. Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol 2006, 144:239-246.
23. Job E.R., Deng Y.M., Tate M.D., Bottazzi B., Crouch E.C., Dean M.M., et al. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 2010, 185:4284-4291.
24. Ip W.K., Chan K.H., Law H.K., Tso G.H., Kong E.K., Wong W.H., et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005, 191:1697-1704.
25. Michelow I.C., Dong M., Mungall B.A., Yantosca L.M., Lear C., Ji X., et al. A novel l-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem 2010, 285:24729-24739.